Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/23793| Title: | Inotuzumab ozogamicin resistance associated with a novel CD22 truncating mutation in a case of B-acute lymphoblastic leukaemia. | Austin Authors: | Ryland, Georgina L;Barraclough, Allison ;Fong, Chun Yew ;Fleming, Shaun;Bajel, Ashish;Hofmann, Oliver;Westerman, David;Grimmond, Sean;Blombery, Piers | Affiliation: | Department of Clinical Haematology, Alfred Hospital, Melbourne, VIC, Australia Department of Clinical Haematology, Austin Health, Heidelberg, Victoria, Australia Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia Centre for Cancer Research, University of Melbourne, Melbourne, VIC, Australia Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, VIC, Australia Olivia Newton-John Cancer Research Institute, Heidelberg, Victoria, Australia |
Issue Date: | Oct-2020 | Date: | 2020-07-09 | Publication information: | British Journal of Haematology 2020; 191(1): 123-126 | URI: | https://ahro.austin.org.au/austinjspui/handle/1/23793 | DOI: | 10.1111/bjh.16949 | ORCID: | 0000-0002-4990-0961 0000-0002-9902-0022 0000-0001-5773-103X |
Journal: | British journal of haematology | PubMed URL: | 32648276 | Type: | Journal Article |
| Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.